Use of Recombinant Human Erythropoietin (r-HuEPO) in a Jehovahʼs Witness Refusing Transfusion of Blood Products
- 1 November 1990
- journal article
- case report
- Published by Wolters Kluwer Health
- Vol. 30 (11) , 1406-1408
- https://doi.org/10.1097/00005373-199011000-00016
Abstract
Recombinant human erythropoietin (r-HuEPO) administration to a Jehovah's witness refusing blood transfusions increased her nadir packed cell volume from 13% to 37% and reticulocyte count from 2% to 17.7%. R-HuEPO may provide an alternative safe and effective therapy in life-threatening anemia when blood transfusions are unacceptable to the patient.Keywords
This publication has 0 references indexed in Scilit: